The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof
Published in The lancet oncology (01.01.2015)
Published in The lancet oncology (01.01.2015)
Get full text
Journal Article
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Robertson, John F R, Prof, Bondarenko, Igor M, Prof, Trishkina, Ekaterina, PhD, Dvorkin, Mikhail, MD, Panasci, Lawrence, Prof, Manikhas, Alexey, MD, Shparyk, Yaroslav, PhD, Cardona-Huerta, Servando, PhD, Cheung, Kwok-Leung, MD, Philco-Salas, Manuel Jesus, MD, Ruiz-Borrego, Manuel, MD, Shao, Zhimin, Prof, Noguchi, Shinzaburo, Prof, Rowbottom, Jacqui, MSc, Stuart, Mary, MD, Grinsted, Lynda M, MSc, Fazal, Mehdi, MD, Ellis, Matthew J, Prof
Published in The Lancet (British edition) (17.12.2016)
Published in The Lancet (British edition) (17.12.2016)
Get full text
Journal Article
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
LYNCH, Thomas J, BONDARENKO, Igor, RECK, Martin, LUFT, Alexander, SERWATOWSKI, Piotr, BARLESI, Fabrice, CHACKO, Raju, SEBASTIAN, Martin, NEAL, Joel, HAOLAN LU, CUILLEROT, Jean-Marie
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Reck, Martin, Dr, Kaiser, Rolf, MD, Mellemgaard, Anders, MD, Douillard, Jean-Yves, Prof, Orlov, Sergey, Prof, Krzakowski, Maciej, Prof, von Pawel, Joachim, MD, Gottfried, Maya, MD, Bondarenko, Igor, Prof, Liao, Meilin, Prof, Gann, Claudia-Nanette, MD, Barrueco, José, PhD, Gaschler-Markefski, Birgit, PhD, Novello, Silvia, Prof
Published in The lancet oncology (01.02.2014)
Published in The lancet oncology (01.02.2014)
Get full text
Journal Article
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Garnett, Sally, Lindemann, Justin P O, Sapunar, Francisco, Martin, Miguel
Published in Journal of clinical oncology (20.10.2010)
Published in Journal of clinical oncology (20.10.2010)
Get full text
Journal Article
Web Resource
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
SOCINSKI, Mark A, BONDARENKO, Igor, IGLESIAS, Jose L, RENSCHLER, Markus F, KARASEVA, Nina A, MAKHSON, Anatoly M, VYNNYCHENKO, Igor, OKAMOTO, Isamu, HON, Jeremy K, HIRSH, Vera, BHAR, Paul, HUI ZHANG
Published in Journal of clinical oncology (10.06.2012)
Published in Journal of clinical oncology (10.06.2012)
Get full text
Journal Article
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
BOKEMEYER, Carsten, BONDARENKO, Igor, LOOS, Anja H, ZUBEL, Angela, KORALEWSKI, Piotr, MAKHSON, Anatoly, HARTMANN, Joerg T, APARICIO, Jorge, DE BRAUD, Filippo, DONEA, Serban, LUDWIG, Heinz, SCHUCH, Gunter, STROH, Christopher
Published in Journal of clinical oncology (10.02.2009)
Published in Journal of clinical oncology (10.02.2009)
Get full text
Journal Article
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18
Finn, Richard S, Crown, John P, Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M, Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T, Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J
Published in Breast cancer research : BCR (28.06.2016)
Published in Breast cancer research : BCR (28.06.2016)
Get full text
Journal Article
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial
Di Leo, Angelo, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N, Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L, Smirnova, Iya, Lichinitser, Mikhail R, Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Published in JNCI : Journal of the National Cancer Institute (01.01.2014)
Get full text
Journal Article
Web Resource
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
MOTZER, Robert J, NOSOV, Dmitry, KOGAN, Mikhail, ALEKSEEV, Boris Y, STERNBERG, Cora N, SZCZYLIK, Cezary, CELLA, David, IVANESCU, Cristina, KRIVOSHIK, Andrew, STRAHS, Andrew, ESTEVES, Brooke, BERKENBLIT, Anna, EISEN, Timothy, HUTSON, Thomas E, BONDARENKO, Igor, LESOVOY, Vladimir, LIPATOV, Oleg, TOMCZAK, Piotr, LYULKO, Oleksiy, ALYASOVA, Anna, HARZA, Mihai
Published in Journal of clinical oncology (20.10.2013)
Published in Journal of clinical oncology (20.10.2013)
Get full text
Journal Article
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
ROBERT, Nicholas J, DIERAS, Véronique, PHAN, See-Chun, O'SHAUGHNESSY, Joyce, GLASPY, John, BRUFSKY, Adam M, BONDARENKO, Igor, LIPATOV, Oleg N, PEREZ, Edith A, YARDLEY, Denise A, CHAN, Stephen Y. T, XIAN ZHOU
Published in Journal of clinical oncology (01.04.2011)
Published in Journal of clinical oncology (01.04.2011)
Get full text
Journal Article
First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
BERGH, Jonas, BONDARENKO, Igor M, CHAN, Arlene, DELALOGE, Suzette, XIN HUANG, KERN, Kenneth A, GIORGETTI, Carla, LICHINITSER, Mikhail R, LILJEGREN, Annelie, GREIL, Richard, VOYTKO, Nataliya L, MAKHSON, Anatoly N, CORTES, Javier, LORTHOLARY, Alain, BISCHOFF, Joachim
Published in Journal of clinical oncology (20.03.2012)
Published in Journal of clinical oncology (20.03.2012)
Get full text
Journal Article
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
WOLFF, Antonio C, LAZAR, Ann A, CHAN, Arlene, HACHEMI, Soulef, STRAHS, Andrew, CINCOTTA, Maria, BERKENBLIT, Anna, KRYGOWSKI, Mizue, KANG, Lih Lisa, MOORE, Laurence, HAYES, Daniel F, BONDARENKO, Igor, GARIN, August M, BRINCAT, Stephen, CHOW, Louis, YAN SUN, NESKOVIC-KONSTANTINOVIC, Zora, GUIMARAES, Rodrigo C, FUMOLEAU, Pierre
Published in Journal of clinical oncology (10.01.2013)
Published in Journal of clinical oncology (10.01.2013)
Get full text
Journal Article
Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma
Dang, Nam H., Ogura, Michinori, Castaigne, Sylvie, Fayad, Luis E., Jerkeman, Mats, Radford, John, Pezzutto, Antonio, Bondarenko, Igor, Stewart, Douglas A., Shnaidman, Michael, Sullivan, Sharon, Vandendries, Erik, Tobinai, Kensei, Ramchandren, Radhakrishnan, Hamlin, Paul A., Giné, Eva, Ando, Kiyoshi
Published in British journal of haematology (01.08.2018)
Published in British journal of haematology (01.08.2018)
Get full text
Journal Article
Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study
O'Byrne, Kenneth J, Prof, Gatzemeier, Ulrich, MD, Bondarenko, Igor, MD, Barrios, Carlos, MD, Eschbach, Corinna, MD, Martens, Uwe M, MD, Hotko, Yevhen, MD, Kortsik, Cornelius, MD, Paz-Ares, Luis, MD, Pereira, Jose R, MD, von Pawel, Joachim, MD, Ramlau, Rodryg, MD, Roh, Jae-Kyung, Prof, Yu, Chih-Teng, MD, Stroh, Christopher, PhD, Celik, Ilhan, Prof, Schueler, Armin, MS, Pirker, Robert, Prof
Published in The lancet oncology (01.08.2011)
Published in The lancet oncology (01.08.2011)
Get full text
Journal Article
Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)
SCHMOLL, Hans-Joachim, CUNNINGHAM, David, SALAZAR, Ramon, BARKER, Peter, MOOKERJEE, Bijoyesh, ROBERTSON, Jane, VAN CUTSEM, Eric, SOBRERO, Alberto, KARAPETIS, Christos S, ROUGIER, Philippe, KOSKI, Sheryl L, KOCAKOVA, Ilona, BONDARENKO, Igor, BODOKY, György, MAINWARING, Paul
Published in Journal of clinical oncology (10.10.2012)
Published in Journal of clinical oncology (10.10.2012)
Get full text
Journal Article
Analysis of the Mathematical Model of Open Coaxial Measuring Microwave Converters
Chang, Liu, Panchenko, Alexander, Nikolaevich, Bondarenko Igor, Ilver, Ibraimov
Published in Mobile networks and applications (01.08.2020)
Published in Mobile networks and applications (01.08.2020)
Get full text
Journal Article
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel
Gladkov, Oleg, Moiseyenko, Vladimir, Bondarenko, Igor N., Shparyk, Yaroslav, Barash, Steve, Adar, Liat, Avisar, Noa
Published in The oncologist (Dayton, Ohio) (01.01.2016)
Published in The oncologist (Dayton, Ohio) (01.01.2016)
Get full text
Journal Article
Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC)
Syrigos, Konstantinos, Abert, Istvan, Andric, Zoran, Bondarenko, Igor N, Dvorkin, Mikhail, Galic, Kristina, Galiulin, Rinat, Kuchava, Vladimer, Sriuranpong, Virote, Trukhin, Dmytro, Zhavrid, Edvard, Fu, Dongyue, Kassalow, Laurent M, Jones, Stephanie, Bashir, Zahid
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2021)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2021)
Get full text
Journal Article